Global Economic Outlook and COVID-19 Updates

Former White House medical advisor Anthony Fauci has refused to answer specific questions during a congressional inquiry into the origins of COVID-19. The refusal centers on his testimony regarding the early response to the pandemic and the research conducted at the Wuhan Institute of Virology in China, according to reports from July 29, 2026.

The development follows a series of hearings by U.S. lawmakers seeking to determine whether federal funding from the National Institutes of Health (NIH) contributed to “gain-of-function” research—experiments that enhance the potency or transmissibility of a virus—at the Wuhan facility. Fauci, who led the National Institute of Allergy and Infectious Diseases (NIAID) for decades, has consistently maintained that the U.S. government did not fund research that created the SARS-CoV-2 virus.

Lawmakers have questioned the precision of the definitions used to describe gain-of-function research and whether those definitions were manipulated to avoid oversight. The conflict involves a disagreement between the NIH’s internal classifications and the interpretations of some members of Congress regarding the nature of the grants awarded to EcoHealth Alliance, a U.S.-based nonprofit that collaborated with scientists in Wuhan.

The refusal to answer certain questions during the proceedings has led to accusations from congressional critics that the former official is obstructing the investigation. Supporters of Fauci argue that the questions are politically motivated and that the scientific consensus continues to lean toward a natural zoonotic origin for the virus, though the “lab leak” theory remains a subject of active government review.

The inquiry focuses on several key areas of the early 2020 timeline:

• The timing of the initial alerts received by the NIH regarding unusual pneumonia cases in Hubei province.
• The specific nature of the bat coronavirus research funded by U.S. grants.
• The internal communications between top health officials during February 2020 regarding the possibility of a laboratory origin.

The U.S. Department of Energy and the FBI have previously indicated “low” to “moderate” confidence in the theory that the virus emerged from a laboratory accident, while other U.S. intelligence agencies maintain that a natural spillover from animals to humans is more likely. These conflicting assessments from within the U.S. intelligence community have fueled the ongoing congressional push for more transparent testimony from health officials.

Fauci’s tenure as a primary public face of the U.S. pandemic response made him a central figure in both scientific guidance and political disputes. The current refusal to provide certain answers marks a continuation of a legal and political standoff over the transparency of the U.S. government’s relationship with Chinese research institutions during the early stages of the global health crisis.